An
in vitro antibacterial activity of Cathomycin, a preparation of novobiocin, had been compared with that of erythromycin.
Almost no antibacterial activity of the antibiotics was observed on
Salmonella and
Escherichiac oil, whereas the activity on
Vibrio and
Proteus were higher than that of erythromycin, and that on
Shigella was the same degree as that of erythromycin.
Recently, since macrolide antibio tics might have been applied for the treatment of dysentry cases, we investigated the
in vitro antibacterial activity of Cathomycin on
Shigella. The results indicated that Cathomycin had exhibited an antibacterial activity near to that of erythromycin on
Shigella. Hence, the antibiotics was possibly applied to the treatment of the infection due to
Shigella resistant to antibiotics.
Although Cathomycin had shown moderate degree of antibacterial activity on
Proteus, which have had natural resitancy to various chemotherapeutics, its therapeutical effects on Proteus infections might be expected according to usage, because it was more sensitive than erythromycin on
Proteus mirabilis.Because Cathomycin also had demonstrated clearly higher activity than that of erythrom ycin on
Vibrio El-Tor and
V. parahaemolytics, it would be suggested that the antibiotic might be fairly effective in the treatment of infection ascribed to these Vibrios.
On the other hand, Cathomycin showed an almost similar antibacterial activity to that of erythromycin on
Neisseria gonorrhoeae and
Staphylococcus aureus, and exhibited the activity enough to inhibit their growth As for the antibacterial effects on
Diplococcus pneumoniae and
Streptococcus pyogenes, however, Cathomycin was inferior to erythromycin. Besides, no antibacterial activity of Cathomycin was found on
Clostridum perfringens, but the activity was significantly effective on
Corynebacterium diphtheriae.
View full abstract